These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Anti-VEGF and its impact on the outer retina: retinal pigment epithelium tear after an injection of aflibercept in contralateral eye. Campos Polo R; Rubio Sánchez C Arch Soc Esp Oftalmol; 2016 May; 91(5):245-9. PubMed ID: 26899882 [TBL] [Abstract][Full Text] [Related]
31. Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy. Okamoto T; Shinoda H; Kurihara T; Nagai N; Tsubota K; Ozawa Y BMC Ophthalmol; 2014 Sep; 14():114. PubMed ID: 25270019 [TBL] [Abstract][Full Text] [Related]
32. Retinal pigment epithelial tear after intravitreal ranibizumab. Bakri SJ; Kitzmann AS Am J Ophthalmol; 2007 Mar; 143(3):505-7. PubMed ID: 17317396 [TBL] [Abstract][Full Text] [Related]
33. [Visual and anatomical outcomes of three intravitreal aflibercept injections in eyes with neovascular form of age-related macular degeneration]. Kałuiny JJ; Majer A; Jaworowska-Cieślińska I Klin Oczna; 2015; 117(1):9-13. PubMed ID: 26349151 [TBL] [Abstract][Full Text] [Related]
34. Intraocular Pharmacokinetics of Aflibercept and Vascular Endothelial Growth Factor-A. Celik N; Scheuerle A; Auffarth GU; Kopitz J; Dithmar S Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5574-8. PubMed ID: 26305529 [TBL] [Abstract][Full Text] [Related]
35. Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration. Zinkernagel MS; Wolf S; Ebneter A Ophthalmologica; 2016; 235(1):42-8. PubMed ID: 26540259 [TBL] [Abstract][Full Text] [Related]
36. Macular hole after intravitreal ranibizumab injection for polypoidal choroidal vasculopathy. Cho JH; Park SE; Han JR; Kim HK; Nam WH Clin Exp Optom; 2011 Nov; 94(6):586-8. PubMed ID: 21517972 [TBL] [Abstract][Full Text] [Related]
37. Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Chiang A; Chang LK; Yu F; Sarraf D Retina; 2008 Oct; 28(9):1265-9. PubMed ID: 18628724 [TBL] [Abstract][Full Text] [Related]
38. Correlation Between Hyperreflective Foci and Clinical Outcomes in Neovascular Age-Related Macular Degeneration After Switching to Aflibercept. Abri Aghdam K; Pielen A; Framme C; Junker B Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6448-55. PubMed ID: 26444725 [TBL] [Abstract][Full Text] [Related]
39. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration. Munk MR; Ceklic L; Ebneter A; Huf W; Wolf S; Zinkernagel MS Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506 [TBL] [Abstract][Full Text] [Related]
40. An Uncommon Aflibercept Side Effect: Full Thickness Macular Hole Formation After Intravitreal Injections in Patients With Pre-existing Vitreomacular Traction. Karamitsos A; Sorkou KN; Bhagey J; Hillier RJ; Papastavrou VT Cureus; 2021 Jan; 13(1):e12872. PubMed ID: 33633901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]